Efficacy of bromocriptine for the treatment of peripartum cardiomyopathy: an updated meta-analysis

29 August 2025 (07:00 - 18:00)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Julia Christina Lueg

Charité - University Medicine Berlin, Berlin (Germany)

4 More presentations in this session

Presentation thumbnail

Impact of pregnancy on mortality in dilated cardiomyopathy. Immediate and 12- months postpartum outcomes. Data from the InCor Registry.

Doctor M. Avila Samuel (Sao Paulo, BR)

Abstract Slides Video

Presentation thumbnail

Pregnancy outcomes in women with a bicuspid aortic valve and aortopathy: data from the EORP ESC Registry of Pregnancy and Cardiac Disease (ROPAC) III

Professor J. Roos-Hesselink (Rotterdam, NL)

Abstract Slides Video

Presentation thumbnail

Increasing incidence of venous thromboembolism in first-time pregnancies - A Danish nationwide cohort study on 691,711 women

Ms C. Sindet-Pedersen (Hellerup, DK)

Abstract Slides Video

Presentation thumbnail

Causes and predictors of maternal mortality in pregnant women with heart disease: data from the Brazilian Pregnancy and Heart Disease Registry (REBECGA-Trial)

Doctor M. Avila Samuel (Sao Paulo, BR)

Abstract Slides Video

Access the full session

Session thumbnail

Heart disease in pregnancy: new therapeutic opportunities

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

You may be interested in

Congress Presentation

Bromocriptine treatment and outcome in patients with peripartum cardiomyopathy: the EORP PPCM registry

Congress Presentation

Presentation of Case 3: peripartum cardiomyopathy

Congress Presentation

From childbirth to heart failure: a clinical case of peripartum cardiomyopathy

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources